Literature DB >> 35018940

Structure-affinity relationships of reversible proline analog inhibitors targeting proline dehydrogenase.

Alexandra N Bogner1, John J Tanner1,2.   

Abstract

Proline dehydrogenase (PRODH) catalyzes the first step of proline catabolism, the FAD-dependent oxidation of L-proline to Δ1-pyrroline-5-carboxylate. PRODH plays a central role in the metabolic rewiring of cancer cells, which has motivated the discovery of inhibitors. Here, we studied the inhibition of PRODH by 18 proline-like compounds to understand the structural and chemical features responsible for the affinity of the best-known inhibitor, S-(-)-tetrahydro-2-furoic acid (1). The compounds were screened, and then six were selected for more thorough kinetic analysis: cyclobutane-1,1-dicarboxylic acid (2), cyclobutanecarboxylic acid (3), cyclopropanecarboxylic acid (4), cyclopentanecarboxylic acid (16), 2-oxobutyric acid (17), and (2S)-oxetane-2-carboxylic acid (18). These compounds are competitive inhibitors with inhibition constants in the range of 1.4-6 mM, compared to 0.3 mM for 1. Crystal structures of PRODH complexed with 2, 3, 4, and 18 were determined. All four inhibitors bind in the proline substrate site, but the orientations of their rings differ from that of 1. The binding of 3 and 18 is accompanied by compression of the active site to enable nonpolar contacts with Leu513. Compound 2 is unique in that the additional carboxylate displaces a structurally conserved water molecule from the active site. Compound 18 also destabilizes the conserved water, but by an unexpected non-steric mechanism. The results are interpreted using a chemical double mutant thermodynamic cycle. This analysis revealed unanticipated synergism between ring size and hydrogen bonding to the conserved water. These structure-affinity relationships provide new information relevant to the development of new inhibitor design strategies targeting PRODH.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35018940      PMCID: PMC8864676          DOI: 10.1039/d1ob02328d

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  40 in total

1.  Redox-induced changes in flavin structure and roles of flavin N(5) and the ribityl 2'-OH group in regulating PutA--membrane binding.

Authors:  Weimin Zhang; Min Zhang; Weidong Zhu; Yuzhen Zhou; Srimevan Wanduragala; Dustin Rewinkel; John J Tanner; Donald F Becker
Journal:  Biochemistry       Date:  2007-01-16       Impact factor: 3.162

Review 2.  Proline metabolism in cancer.

Authors:  Pengyu Geng; Wangshu Qin; Guowang Xu
Journal:  Amino Acids       Date:  2021-08-14       Impact factor: 3.520

3.  Structures of the PutA peripheral membrane flavoenzyme reveal a dynamic substrate-channeling tunnel and the quinone-binding site.

Authors:  Harkewal Singh; Benjamin W Arentson; Donald F Becker; John J Tanner
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-18       Impact factor: 11.205

4.  Structures of the Escherichia coli PutA proline dehydrogenase domain in complex with competitive inhibitors.

Authors:  Min Zhang; Tommi A White; Jonathan P Schuermann; Berevan A Baban; Donald F Becker; John J Tanner
Journal:  Biochemistry       Date:  2004-10-05       Impact factor: 3.162

5.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

6.  How good are my data and what is the resolution?

Authors:  Philip R Evans; Garib N Murshudov
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2013-06-13

7.  Polder maps: improving OMIT maps by excluding bulk solvent.

Authors:  Dorothee Liebschner; Pavel V Afonine; Nigel W Moriarty; Billy K Poon; Oleg V Sobolev; Thomas C Terwilliger; Paul D Adams
Journal:  Acta Crystallogr D Struct Biol       Date:  2017-02-01       Impact factor: 7.652

8.  Proline metabolism supports metastasis formation and could be inhibited to selectively target metastasizing cancer cells.

Authors:  Ilaria Elia; Dorien Broekaert; Stefan Christen; Ruben Boon; Enrico Radaelli; Martin F Orth; Catherine Verfaillie; Thomas G P Grünewald; Sarah-Maria Fendt
Journal:  Nat Commun       Date:  2017-05-11       Impact factor: 14.919

9.  In crystallo screening for proline analog inhibitors of the proline cycle enzyme PYCR1.

Authors:  Emily M Christensen; Alexandra N Bogner; Anke Vandekeere; Gabriela S Tam; Sagar M Patel; Donald F Becker; Sarah-Maria Fendt; John J Tanner
Journal:  J Biol Chem       Date:  2020-10-27       Impact factor: 5.157

10.  N-Propargylglycine: a unique suicide inhibitor of proline dehydrogenase with anticancer activity and brain-enhancing mitohormesis properties.

Authors:  Gary K Scott; Sophia Mahoney; Madeleine Scott; Ashley Loureiro; Alejandro Lopez-Ramirez; John J Tanner; Lisa M Ellerby; Christopher C Benz
Journal:  Amino Acids       Date:  2021-06-05       Impact factor: 3.520

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.